PFE
Pfizer Inc.
- Research and development, 2025
- $10.4B
- YoY, 2025
- −3.6%
- 5-year CAGR
- +3.7%
- 10-year CAGR
- +3.1%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $10.4B | −3.6% |
| 2024 | $10.8B | +1.3% |
| 2023 | $10.7B | −6.6% |
| 2022 | $11.4B | +10.3% |
| 2021 | $10.4B | +19.0% |
| 2020 | $8.7B | +3.9% |
| 2019 | $8.4B | +8.1% |
| 2018 | $7.8B | +1.0% |
| 2017 | $7.7B | −2.6% |
| 2016 | $7.9B | +2.6% |
| 2015 | $7.7B | −8.4% |
| 2014 | $8.4B | +25.7% |
| 2013 | $6.7B | −10.7% |
| 2012 | $7.5B | −13.8% |
| 2011 | $8.7B | −8.5% |
| 2010 | $9.5B | +21.2% |
| 2009 | $7.8B | −1.5% |
| 2008 | $7.9B | −1.8% |
| 2007 | $8.1B | — |